Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Chat with Yara.AI
Your financial questions, answered anytime, instantly.
Cibil Report
Get cibil report
Do not call
En
Everest Organics Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹252.00 |
|---|---|
| Day's Range | ₹240.00 - ₹252.00 |
| Open | ₹241.25 |
| 52 Week Range | ₹197.00 - ₹536.40 |
| Volume | 386 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.95 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 51.29 |
| TTM EPS (₹) | 4.91 |
| P/E Ratio | 35.62 |
| Book Value(₹) | 3.13 |
| PAT Margin (%) | 2.46 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.98 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 510.02 | 1594.79 |
| Expenses | N/A | N/A |
| PBT | 26.74 | -32.42 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 11.56 | -12.9 |
About Everest Organics Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | Srikakarlapudi Sirisha |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,290.91 | 1,880.90 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 3,05,014.11 | 11,489.65 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,77,333.20 | 4,662.15 | 3,672.30 - 3,672.30 |
| Laurus Labs Ltd. | 1,30,755.56 | 2,420.00 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,26,550.66 | 726.30 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,22,439.82 | 8,515.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,18,802.71 | 1,191.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,15,016.89 | 1,377.00 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,12,538.81 | 1,393.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,09,622.17 | 2,654.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Nov
13
2026
Posted on Nov 13th 2026
Everest Organics informs about newspaper publication
Everest Organics has enclosed copies of the newspaper advertisement published by the Company in the newspapers, i.e., The South India Times (English) and Teluguprabha (Regional), on Friday, November 13, 2026, regarding the publication of the Unaudited (Standalone) Financial Results of the Company for the quarter and half year ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
17
2026
Posted on Aug 17th 2026
Everest Organics informs about newspaper publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Everest Organics has enclosed copies of the newspaper advertisement published by the Company on Saturday, August 15, 2026, in the following newspapers, intimating the publication of the Company's unaudited Standalone Financial Results for the quarter ended June 30, 2026: 1. The South India Times (English), 2. Telugu Prabha (Regional).
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
14
2026
Posted on Nov 14th 2026
KMC Speciality Hosp. - Quaterly Results
The company witnessed a 24.08% growth in the revenue at Rs. 929.37 millions for the quarter ended September 2026 as compared to Rs. 749.02 millions during the year-ago period.A good growth in profit of 49.64% reported to Rs. 162.23 millions over Rs. 108.41 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 297.61 millions from 220.89 millions in the quarter ended September 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 929.37 | 749.02 | 24.08 | 1847.14 | 1414.55 | 30.58 | 3057.68 | 2315.98 | 32.03 |
| Other Income | 14.58 | 12.44 | 17.20 | 32.66 | 20.45 | 59.71 | 50.76 | 30.86 | 64.48 |
| PBIDT | 297.61 | 220.89 | 34.73 | 600.54 | 393.41 | 52.65 | 930.02 | 599.71 | 55.08 |
| Interest | 19.31 | 20.45 | -5.57 | 39.34 | 42.09 | -6.53 | 83.07 | 94.16 | -11.78 |
| PBDT | 278.30 | 200.44 | 38.84 | 561.20 | 351.32 | 59.74 | 846.95 | 505.55 | 67.53 |
| Depreciation | 61.92 | 53.04 | 16.74 | 120.44 | 103.86 | 15.96 | 216.71 | 189.52 | 14.35 |
| PBT | 216.38 | 147.40 | 46.80 | 440.76 | 247.46 | 78.11 | 630.24 | 316.03 | 99.42 |
| TAX | 54.15 | 38.99 | 38.88 | 112.80 | 63.70 | 77.08 | 162.89 | 101.76 | 60.07 |
| Deferred Tax | -2.95 | 5.24 | -156.30 | -7.21 | -0.90 | 701.11 | 3.77 | 28.68 | -86.85 |
| PAT | 162.23 | 108.41 | 49.64 | 327.96 | 183.76 | 78.47 | 467.35 | 214.27 | 118.11 |
| Equity | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 |
| PBIDTM(%) | 32.02 | 29.49 | 8.59 | 32.51 | 27.81 | 16.90 | 30.42 | 25.89 | 17.46 |
Read More
Nov
14
2026
Posted on Nov 14th 2026
Natco Pharma - Quaterly Results
The Sales for the quarter ended September 2026 of Rs. 8545.00 million declined by -32.41% from Rs. 12643.00 millions.Net profit of the cmpany stood at Rs. 1432.00 millions for the quarter ended September 2026 a decline of -71.41% from Rs. 5009.00 millions in the same quarter last year.The Operating Profit of the company witnessed a decrease to 2566.00 millions from 6458.00 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 8545.00 | 12643.00 | -32.41 | 14511.00 | 24570.00 | -40.94 | 35946.00 | 40945.00 | -12.21 |
| Other Income | 403.00 | 933.00 | -56.81 | 886.00 | 1529.00 | -42.05 | 2811.00 | 3213.00 | -12.51 |
| PBIDT | 2566.00 | 6458.00 | -60.27 | 4109.00 | 12451.00 | -67.00 | 15860.00 | 24656.00 | -35.67 |
| Interest | 156.00 | 117.00 | 33.33 | 252.00 | 143.00 | 76.22 | 323.00 | 196.00 | 64.80 |
| PBDT | 2410.00 | 6341.00 | -61.99 | 3857.00 | 12308.00 | -68.66 | 15537.00 | 24460.00 | -36.48 |
| Depreciation | 440.00 | 481.00 | -8.52 | 867.00 | 1019.00 | -14.92 | 1896.00 | 2200.00 | -13.82 |
| PBT | 1970.00 | 5860.00 | -66.38 | 2990.00 | 11289.00 | -73.51 | 13641.00 | 22260.00 | -38.72 |
| TAX | 538.00 | 851.00 | -36.78 | 812.00 | 1639.00 | -50.46 | 826.00 | 3756.00 | -78.01 |
| Deferred Tax | 314.00 | -455.00 | -169.01 | 478.00 | -727.00 | -165.75 | -1858.00 | -319.00 | 482.45 |
| PAT | 1432.00 | 5009.00 | -71.41 | 2178.00 | 9650.00 | -77.43 | 12815.00 | 18504.00 | -30.74 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 30.03 | 51.08 | -41.21 | 28.32 | 50.68 | -44.12 | 44.12 | 60.22 | -26.73 |
Read More
Nov
14
2026
Posted on Nov 14th 2026
Park Medi World - Quaterly Results
A decent increase of about 48.26% in the sales to Rs. 340.54 millions was observed for the quarter ended September 2026. The sales figure stood at Rs. 229.69 millions during the year-ago period.The Net Loss for the quarter ended September 2026 is Rs. -6.57 millions as compared to Net Profit of Rs. 48.96 millions of corresponding quarter ended September 2025A decline of 54.72 millions was observed in the OP in the quarter ended September 2026 from 105.50 millions on QoQ basis.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 340.54 | 229.69 | 48.26 | 675.86 | 459.38 | 47.12 | 1289.65 | 915.82 | 40.82 |
| Other Income | 41.70 | 2.00 | 1985.00 | 88.38 | 4.01 | 2103.99 | 103.35 | 20.70 | 399.28 |
| PBIDT | 54.72 | 105.50 | -48.13 | 114.24 | 211.02 | -45.86 | 627.05 | 261.09 | 140.17 |
| Interest | 17.23 | 32.97 | -47.74 | 25.83 | 65.95 | -60.83 | 127.55 | 123.43 | 3.34 |
| PBDT | 37.49 | 72.53 | -48.31 | 88.41 | 145.07 | -39.06 | 499.50 | 137.66 | 262.85 |
| Depreciation | 43.61 | 11.62 | 275.30 | 77.42 | 23.23 | 233.28 | 45.09 | 48.62 | -7.26 |
| PBT | -6.12 | 60.91 | -110.05 | 10.99 | 121.84 | -90.98 | 454.41 | 89.04 | 410.34 |
| TAX | 0.45 | 11.95 | -96.23 | 6.72 | 23.91 | -71.89 | 88.25 | 17.24 | 411.89 |
| Deferred Tax | -2.59 | -0.13 | 1892.31 | 0.24 | -0.26 | -192.31 | -24.50 | -20.83 | 17.62 |
| PAT | -6.57 | 48.96 | -113.42 | 4.27 | 97.93 | -95.64 | 366.16 | 71.80 | 409.97 |
| Equity | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 |
| PBIDTM(%) | 16.07 | 45.93 | -65.02 | 16.90 | 45.94 | -63.20 | 48.62 | 28.51 | 70.55 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Everest Organics Ltd. is ₹252.00 as of 2026-11-13.
The market capitalisation of Everest Organics Ltd. is ₹251.34 as of 2026-11-13.
The 1-year return of Everest Organics Ltd. is -155.85% as of 2026-11-13.
The P/E ratio of Everest Organics Ltd. is 35.62 as of 2026-11-14.
The 52-week high and low of Everest Organics Ltd. are ₹536.40 and ₹197.00, respectively, as of 2026-11-13.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
